Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novo Nordisk A/S B (OP: NONOF ) 118.50 +3.00 (+2.60%) Streaming Delayed Price Updated: 10:51 AM EDT, Oct 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 662 Open 119.00 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 115.50 Today's Range 112.06 - 119.00 52wk Range 90.70 - 149.55 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Novo Nordisk's Wegovy Demonstrates Greater Weight Loss In Women With Heart Condition June 24, 2024 The greater weight loss in women did not result in significantly better improvements in heart failure symptoms. Via Benzinga Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss June 21, 2024 As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide. Via Benzinga Performance YTD +17.09% +17.09% 1 Month -8.85% -8.85% 3 Month -16.16% -16.16% 6 Month -5.22% -5.22% 1 Year +29.04% +29.04% More News Read More The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash June 07, 2024 Via InvestorPlace Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments May 14, 2024 Via Benzinga 7 Mutual Funds That Will Outperform in Any Market February 03, 2024 Via InvestorPlace Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label September 11, 2023 Via Benzinga Emmanuel Macron To Unveil Novo Nordisk Record $2.3B Investment In France's Health Sector November 23, 2023 Via Benzinga Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them October 09, 2023 Via Benzinga Diabetes Drug Ozempic May Hold Key to Breaking Addictions: The Guardian July 03, 2023 Via Benzinga Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert August 17, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
